Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: real-world data from a retrospective multicenter study

• Main Authors: Ilteris Oguz Topal (Author), Sevim Baysak (Author), İlknur Kıvanç Altunay (Author), Asude Kara Polat (Author), Eylem Emel Arıkan (Author), Ezgi Özkur (Author), Sema Aytekin (Author), Bilal Dogan (Author), Tuǧba Özkök Akbulut (Author), Filiz Topaloǧlu Demir (Author), Ayșe Serap Karadaǧ (Author)
• Format: Book
• Published: Sociedade Brasileira de Dermatologia, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background: Clinical studies have demonstrated that IL-17A inhibition with secukinumab is effective for clearing the skin of patients with psoriasis and has a favorable safety profile. Objective: The authors aim to determine whether secukinumab is effective and safe for the treatment of mod...